Skip to content
Back to treatments
Regenerative Medicine~67% less than U.S.

Stem Cell Therapy for Liver Disease

肝病干细胞治疗

Duration
2-4 weeks for treatment course
Recovery
1-2 weeks post-procedure; liver function improvement over 3-6 months
Average savings
67%
价格对比Price comparison

China versus the U.S.

China
$10,000
Range: $5,000–$15,000
United States
$30,000
Range: $15,000–$45,000
You save
67%
~$20,000 per procedure
China clinical rate
$5,000 – $15,000
$10,000
United States
$15,000 – $45,000
$30,000
You save
~67%
$20,000 per procedure

Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.

关于About this treatment

What the procedure involves.

Mesenchymal stem cell therapy for chronic liver diseases including cirrhosis, liver fibrosis, and liver failure. China's hepatology centers are global leaders in liver stem cell research, leveraging high patient volumes and advanced cell manufacturing facilities. Treatment aims to promote hepatocyte regeneration, reduce fibrosis, and improve liver function as a bridge to or alternative to transplantation.

流程Procedure steps

Step by step.

  1. 01

    Liver Function Assessment

    Child-Pugh scoring, MELD calculation, FibroScan, MRI, and comprehensive hepatic panel

    Duration · 2-3 days
  2. 02

    Cell Preparation

    Allogeneic umbilical cord MSC or autologous bone marrow MSC preparation under GMP conditions

    Duration · 1-2 weeks
  3. 03

    Cell Delivery

    Hepatic artery infusion or peripheral intravenous administration of stem cells

    Duration · 1-3 sessions over 1-2 weeks
  4. 04

    Post-treatment Monitoring

    Serial liver function tests, imaging follow-up, and fibrosis marker assessment

    Duration · Monthly for 6-12 months
Benefits
  • China has the largest clinical experience with liver stem cell therapy
  • May improve liver function and reduce fibrosis progression
  • Potential alternative for patients ineligible for transplantation
  • Minimally invasive compared to surgical interventions
Considerations
  • Experimental treatment with variable outcomes
  • Temporary fever and discomfort after cell infusion
  • Not a proven substitute for liver transplantation in end-stage disease
  • Portal hypertension may limit hepatic artery delivery
下一步Next step

Ask the AI for hospitals that handle stem cell therapy for liver disease.

Ask AIRequest consultation

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.